<DOC>
	<DOCNO>NCT02224651</DOCNO>
	<brief_summary>This single ascend dose study first evaluation PF-06650833 human . The goal assess safety , tolerability blood level ascend dos multiple formulation PF-06650833 perform preliminary assessment effect food exposure , healthy subject .</brief_summary>
	<brief_title>Study Evaluate Safety Tolerability Single Ascending Doses Multiple Formulations PF-06650833 Healthy Subjects Under Fasted Fed Conditions</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject non childbearing potential age 18 55 year , inclusive . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Screening supine blood pressure 100 mm Hg ( systolic ) 50 mm Hg ( diastolic ) ; 140 mm Hg ( systolic ) 90 mm Hg ( diastolic ) follow least 5 minute supine rest . If blood pressure ( BP ) 140 mm Hg ( systolic ) 90 mm Hg ( diastolic ) , BP repeat two time average three BP value use determine subject 's eligibility . Pulse heart rate ( HR ) &gt; 100 bpm least 5 minute rest . If pulse/HR &gt; 100 bpm , pulse/HR repeat two time ( separate least 2 minute ) average three pulse/HR value use determine subject 's eligibility .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>